Skip to main content
Top
Published in: Clinical Sarcoma Research 1/2016

Open Access 01-12-2016 | Meeting Report

The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24–25, 2015. Workshop Report

Authors: Leo Kager, Jeremy Whelan, Uta Dirksen, Bass Hassan, Jakob Anninga, Lindsey Bennister, Judith V. M. G. Bovée, Bernadette Brennan, Javier M. Broto, Laurence Brugières, Anne-Marie Cleton-Jansen, Christopher Copland, Aurélie Dutour, Franca Fagioli, Stefano Ferrari, Marta Fiocco, Emmy Fleuren, Nathalie Gaspar, Hans Gelderblom, Craig Gerrand, Joachim Gerß, Ornella Gonzato, Winette van der Graaf, Stefanie Hecker-Nolting, David Herrero-Martín, Stephanie Klco-Brosius, Heinrich Kovar, Ruth Ladenstein, Carlo Lancia, Marie-Cecile LeDeley, Martin G. McCabe, Markus Metzler, Ola Myklebost, Michaela Nathrath, Piero Picci, Jenny Potratz, Françoise Redini, Günther H.S. Richter, Denise Reinke, Piotr Rutkowski, Katia Scotlandi, Sandra Strauss, David Thomas, Oscar M. Tirado, Franck Tirode, Gilles Vassal, Stefan S. Bielack

Published in: Clinical Sarcoma Research | Issue 1/2016

Login to get access

Abstract

This report summarizes the results of the 3rd Joint ENCCA-WP7, EuroSarc, EEC, PROVABES, and EURAMOS European Bone Sarcoma Network Meeting, which was held at the Children’s Cancer Research Institute in Vienna, Austria on September 24–25, 2015. The joint bone sarcoma network meetings bring together European bone sarcoma researchers to present and discuss current knowledge on bone sarcoma biology, genetics, immunology, as well as results from preclinical investigations and clinical trials, to generate novel hypotheses for collaborative biological and clinical investigations. The ultimate goal is to further improve therapy and outcome in patients with bone sarcomas.
Metadata
Title
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24–25, 2015. Workshop Report
Authors
Leo Kager
Jeremy Whelan
Uta Dirksen
Bass Hassan
Jakob Anninga
Lindsey Bennister
Judith V. M. G. Bovée
Bernadette Brennan
Javier M. Broto
Laurence Brugières
Anne-Marie Cleton-Jansen
Christopher Copland
Aurélie Dutour
Franca Fagioli
Stefano Ferrari
Marta Fiocco
Emmy Fleuren
Nathalie Gaspar
Hans Gelderblom
Craig Gerrand
Joachim Gerß
Ornella Gonzato
Winette van der Graaf
Stefanie Hecker-Nolting
David Herrero-Martín
Stephanie Klco-Brosius
Heinrich Kovar
Ruth Ladenstein
Carlo Lancia
Marie-Cecile LeDeley
Martin G. McCabe
Markus Metzler
Ola Myklebost
Michaela Nathrath
Piero Picci
Jenny Potratz
Françoise Redini
Günther H.S. Richter
Denise Reinke
Piotr Rutkowski
Katia Scotlandi
Sandra Strauss
David Thomas
Oscar M. Tirado
Franck Tirode
Gilles Vassal
Stefan S. Bielack
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Clinical Sarcoma Research / Issue 1/2016
Electronic ISSN: 2045-3329
DOI
https://doi.org/10.1186/s13569-016-0043-5

Other articles of this Issue 1/2016

Clinical Sarcoma Research 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine